Headlands Technologies LLC Incyte Corp Transaction History

Headlands Technologies LLC

  • $834 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$56.55 - $66.59 $1.25 Million - $1.47 Million
22,102 Added 552.96%
26,099 $1.49 Million
Q4 2023

Feb 02, 2024
BUY
$52.16 - $64.19 $208,483 - $256,567
3,997 New
3,997 $250,000
Q2 2023

Aug 03, 2023
BUY
$60.95 - $75.51 $1.88 Million - $2.33 Million
30,798 New
30,798 $1.92 Million

Others Institutions Holding INCY

# of Institutions
644
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email